 versus sezolamide Comparative efficacy active carbonic anhydrase inhibitors Topical carbonic anhydrase inhibitors hydrochloride double-masked placebo-controlled study patients bilateral primary open-angle glaucoma ocular hypertension hours hours placebo hours days drugs intraocular pressure IOP active sezolamide peak mean IOP reduction versus sezolamide difference treatments significant drugs potential treatment glaucoma